This is CuraTeQ’s third biosimilar to be approved by EMA after the approval of Dyrupeg in April 2025 and Zefylti in February ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogsJaguar is exploring the possib ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

💙 Meet the Blue Emperor — a giant among dragonflies and a king of the skies. With its vibrant colors and impressive wingspan, this European beauty is both fast and fascinating.

PRESS RELEASE June 20, 2025 The European Space Agency and Dassault Aviation paving the way for potential collaborations ESA and Dassault Aviation have identified a mutual interest in developing a ...

Partner Therapeutics, Inc. (PTx) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of PTx's Marketing ...

Americas Bluesky briefly suspends US vice president’s account after joining platform Automated systems flagged JD Vance’s account as potential impersonation before quick restoration, says company ...

Blue Jackets Predicted to Land Panthers Star in Free Agency Matt Levine Fri, Jun 20, 2025 · 2 min read ...

PRESS RELEASEThe European Space Agency and Dassault Aviation paving the way for potential collaborations ...